Skip to main content
Premium Trial:

Request an Annual Quote

Genomics One Private Placement Delayed as New Terms Discussed with Investors

NEW YORK, July 4 (GenomeWeb News) - Genomics One said last week that a $500,000 private placement, announced on June 3, has not been concluded under the timeline and terms prescribed by the TSX Ventures Exchange.


The placement was to support the company's biodefense operations.


Genomics One said that it is currently negotiating new terms for the placement with its potential investors. The new terms are subject to TSX Ventures Exchange approval.


The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.